The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus
Abstract Transarterial chemoembolization (TACE) combined with apatinib has been used for advanced hepatocellular carcinoma (HCC), and the efficacy is good. The study was conducted to compare the efficacy and safety of drug-eluting bead TACE plus apatinib (D-TACE-A) with conventional TACE plus apatin...
Main Authors: | Weihua Zhang, Linxia Wu, Lei Chen, Tao Sun, Yanqiao Ren, Bo Sun, Licheng Zhu, Ping Han, Chuansheng Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-09609-8 |
Similar Items
-
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
by: Yanqiao Ren, et al.
Published: (2022-03-01) -
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01) -
Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
by: Junwei Chen, et al.
Published: (2023-07-01) -
Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib
by: Tao Sun, et al.
Published: (2020-12-01) -
Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus
by: Aoran Dong, et al.
Published: (2023-12-01)